Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2014 Results

CRANBURY, N.J., May 9, 2014 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2014 operating results on Tuesday, May 13, 2014 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 13, 2014 at 11:00 a.m. ET. The conference call will include a review on the company’s operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Webcast

Q3 Fiscal Year 2014 Financial Results Press Release

5/13/2014 at 7:30 a.m. ET

Q3 Fiscal Year 2014 Conference Call-Live

5/13/2014 at 11:00 a.m. ET

Domestic Dial-In Number


International Dial-In Number




Q3 Fiscal Year 2014 Conference Call-Replay


Domestic Dial-In Number


International Dial-In Number




Webcast Live and Replay Access


The webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts” section of Palatin’s website at http://www.palatin.com

About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com or follow us on Twitter at http://twitter.com/PalatinTech.

SOURCE Palatin Technologies, Inc.

Scroll to Top